Company Overview and News

 
Osisko Announces the Vote Results from its Annual and Special Meeting of Shareholders

2018-05-04 globenewswire
MONTREAL, May 04, 2018 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (the “Corporation” or “Osisko”) (TSX:OR) (NYSE:OR) announces that, at the annual and special meeting of shareholders held on May 3, 2018, each of the 10 nominees listed in the management information circular filed on March 29, 2018 (the “Circular”) with regulatory authorities were elected as directors of the Corporation.

 
Osisko Closes Financing on Victoria Gold’s Eagle Gold Project

2018-04-16 globenewswire
MONTRÉAL, April 16, 2018 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (TSX:OR) (NYSE:OR) (“Osisko”) is pleased to announce that it has completed the previously announced C$148 million financing transaction (the “Financing”) with Victoria Gold Corp. (TSX-V:VIT) (“Victoria”), pursuant to which Osisko acquired from Victoria a 5% net smelter return (“NSR”) royalty (the “Royalty”) for C$98 million (the “Royalty Purchase”) on the Dublin Gulch property (the “Property”) which hosts the Eagle Gold project located in Yukon, Canada, and purchased from Victoria, on a private placement basis, 100 million common shares of Victoria at a price of C$0.

 
Early Warning News Release

2018-04-02 marketwired
MONTRÉAL, QUÉBEC--(Marketwired - April 2, 2018) - Osisko Gold Royalties Ltd (TSX:OR)(NYSE:OR) ("Osisko") announces that it has subscribed for and received from Niobay Metals Inc. (TSX VENTURE:NBY) ("Niobay") 9,000,000 common shares of Niobay at a price of $0.26 per share by way of a private placement of Niobay, for an aggregate subscription price of $2,340,000 (the "Private Placement"').

 
Globex: Falco Begins 2018 Donalda Mine Drill Program

2018-03-13 marketwired
ROUYN-NORANDA, QUÉBEC--(Marketwired - March 13, 2018) - GLOBEX MINING ENTERPRISES INC. (TSX:GMX)(FRANKFURT:G1MN)(STUTTGART:G1MN)(BERLIN:G1MN)(MUNICH:G1MN)(XETRA:G1MN)(OTCQX:GLBXF) is pleased to report that Falco Resources Ltd. (TSX VENTURE:FPC) ("Falco") has commenced its 2018 exploration program on Globex's Donalda royalty property (See Globex press release dated September 27, 2017). An initial program of 10 holes for a total of 10,000 meters is planned.

 
Osisko Acquires Gold Royalty on Victoria Gold's Fully-Financed, Shovel-Ready Eagle Gold Project in Canada

2018-03-08 marketwired
MONTRÉAL, QUÉBEC--(Marketwired - March 8, 2018) - Osisko Gold Royalties Ltd ("Osisko") (TSX:OR)(NYSE:OR) is pleased to announce that it has signed a term sheet (the "Term Sheet") with Victoria Gold Corp. ("Victoria") to acquire a 5% net smelter return ("NSR") royalty (the "Royalty") for C$98 million (the "Royalty Purchase") on the Dublin Gulch property (the "Property") which hosts the Eagle Gold project ("Eagle" or the "Project") located in Yukon, Canada ("Royalty").

1
Falco Begins 2018 Donalda - Quemont East Drilling Program

2018-02-28 marketwired
MONTREAL, QC--(Marketwired - February 28, 2018) - Falco Resources Ltd. (TSX VENTURE: FPC) ("Falco" or the "Company") is pleased to announce that it has commenced its 2018 exploration program on the Donalda - Quemont East target. An initial program of 20 holes for a total of 20,000 metres is planned to be completed.

1
Osisko Gold Royalties Reports Fourth Quarter and Full Year 2017 Results

2018-02-20 marketwired
MONTREAL, QUEBEC--(Marketwired - Feb. 20, 2018) - Osisko Gold Royalties Ltd (the "Company" or "Osisko") (TSX:OR)(NYSE:OR) is pleased to report its results for the fourth quarter and full year 2017 and provide 2018 guidance. Amounts are in Canadian dollars unless otherwise noted.

 
Osisko Declares 14th Quarterly Dividend

2018-02-20 marketwired
MONTREAL, QUEBEC--(Marketwired - Feb. 20, 2018) - Osisko Gold Royalties Ltd ("Osisko" or the "Company") (TSX:OR) (NYSE:OR) is pleased to announce a first quarter 2018 dividend of C$0.05 per common share. The dividend will be paid on April 16, 2018 to shareholders of record as of the close of business on March 30, 2018.

 
Early Warning News Release

2018-02-17 marketwired
MONTRÉAL, QUÉBEC--(Marketwired - Feb. 16, 2018) - Osisko Gold Royalties Ltd (TSX:OR)(NYSE:OR) ("Osisko") announces that, pursuant to the terms of a share purchase agreement entered into with Alamos Gold Inc. on February 16, 2018, Osisko has acquired direct ownership of 25,300,000 common shares of Corex Gold Corporation ("Corex Gold") at a price of $0.13 per common share (the "Transaction").

 
Early Warning News Release

2018-02-06 marketwired
MONTRÉAL, QUÉBEC--(Marketwired - Feb. 6, 2018) - Osisko Gold Royalties Ltd (TSX:OR) (NYSE:OR) ("Osisko") announces that it has subscribed for and received from Algold Resources Ltd. ("Algold") 14,285,714 units of Algold at a price of $0.14 per unit (the "Units") by way of a private placement of Algold, for an aggregate subscription price of $1,999,999.96 (the "Private Placement"').

 
Osisko Gold Royalties Updates Notice of Fourth Quarter and Full Year 2017 Results and Conference Call Details

2018-01-19 marketwired
MONTREAL, QUÉBEC--(Marketwired - Jan. 19, 2018) - Osisko Gold Royalties Ltd (the "Corporation" or "Osisko") (TSX:OR)(NYSE:OR) announces that its fourth quarter and full year 2017 results will be released before market on Tuesday, February 20, 2018 followed by a conference call the same day, February 20, 2018 at 11:00 am EDT.

 
Osisko Announces Record 2017 Gold Equivalent Ounces

2018-01-18 marketwired
MONTREAL, QUEBEC--(Marketwired - Jan. 18, 2018) - Osisko Gold Royalties Ltd (the "Company" or "Osisko") (TSX:OR)(NYSE:OR) is pleased to announce its preliminary 2017 gold equivalent ounces ("GEOs")1.

 
Globex: Drill Results Pending on Donalda Gold Mine Property

2018-01-10 marketwired
ROUYN-NORANDA, QUÉBEC--(Marketwired - Jan. 10, 2018) - GLOBEX MINING ENTERPRISES INC. (TSX:GMX)(FRANKFURT:G1MN)(STUTTGART:G1MN)(BERLIN:G1MN)(MUNICH:G1MN)(XETRA:G1MN)(OTCQX:GLBXF) is pleased to provide shareholders with an update on exploration by Falco Resources Limited (FPC-TSXV) on Globex's Donalda Royalty Property. Shareholders are reminded that Globex sold the former Donalda Gold Mine property to Falco in September 2017 for $300,000, 350,000 Falco shares, 350,000 five year Falco warrants and a 2.

1
Falco Updates on Horne 5 Project Development and Exploration Activities

2018-01-10 marketwired
MONTREAL, QC--(Marketwired - January 10, 2018) - Falco Resources Ltd. (TSX VENTURE: FPC) ("Falco" or the "Company") is pleased to provide the following update on its development of the Horne 5 Project (the "Project"), exploration and corporate activities.

1
Osisko Portfolio Update

2018-01-09 marketwired
MONTRÉAL, QUÉBEC--(Marketwired - Jan. 9, 2018) - Osisko Gold Royalties Ltd (the "Company" or "Osisko") (TSX:OR)(NYSE:OR) is pleased to provide an update on its investment portfolio. The Company reports that it has delivered its shares of AuRico Metals Inc. ("AuRico") to Centerra Gold Inc. for a $1.80 cash consideration per share and for proceeds of $25.5 million, generating a gain for Osisko of $15.

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

16h - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

17h - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

CUSIP: 30606C959